| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/02/2001 | EP1095159A1 Bone morphogenic protein |
| 05/02/2001 | EP1095154A2 Interaction of human beta amyloid precursor protein (beta-app) with human lon-protease like protein (hslon) |
| 05/02/2001 | EP1095143A2 Method for diagnosis and treatment of haemophilia a patients with an inhibitor |
| 05/02/2001 | EP1095142A2 Molecules associated with cell proliferation |
| 05/02/2001 | EP1095140A2 Neurotrophic factors |
| 05/02/2001 | EP1095139A2 Secreted proteins |
| 05/02/2001 | EP1095062A1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
| 05/02/2001 | EP1095060A1 Galectin 11 |
| 05/02/2001 | EP1095059A1 Chemotaxis inhibiting protein of staphylococcus (chips) and its use |
| 05/02/2001 | EP1095020A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | CN1293206A Single-chain antibody resisting human gastric cancer and its application |
| 05/02/2001 | CN1293204A Polypeptide-human bromo-functional protein 72 and polynucleotide for coding this polypeptide |
| 05/02/2001 | CN1293203A Polypeptide-human zinc finger protein 59 and polynucleotide for coding this polypeptide |
| 05/01/2001 | US6225625 Signal detection methods and apparatus |
| 05/01/2001 | US6225530 Flowering locus T (FT) and genetically modified plants having modulated flower development |
| 05/01/2001 | US6225457 Polynucleotide sequences associated with bacterial proteins; for detection of bactericides |
| 05/01/2001 | US6225455 Constructs for producing phosphorylated fusion proteins |
| 05/01/2001 | US6225449 Hormone analogs with multiple CTP extensions |
| 05/01/2001 | US6225448 1gG /transferrin receptor fusion protein |
| 05/01/2001 | US6225447 Methods for producing members of specific binding pairs |
| 05/01/2001 | US6225286 Cell surface protein expressed on human cortical thymocyte and their use |
| 05/01/2001 | US6225117 Antibodies against human IL-12 |
| 05/01/2001 | US6225103 Protease for use as diagnostic indicator of cancer |
| 05/01/2001 | US6225098 UDP-N-acetylenolpyruvyglucosamine reductase |
| 05/01/2001 | US6225087 Polynucleotide which codes for a polypeptide of defined amino acid sequence; drug screening of bactericides against streptococcus; otitis media; conjunctivitis; pneumonia; meningitis; sinusitis; pleural empyema; endocarditis |
| 05/01/2001 | US6225085 Nucleotide and amino acid sequence of leucine-rich surface glycoprotein; diagnosis; prophylaxis; therapy; drug screening; fusion proteins; antigenic peptides; antibodies; recombinant production |
| 05/01/2001 | US6225083 Nucleotide and amino acid sequences of membrane protein involved in cell division; drug screening; bactericides; bacteriostats; antibiotics; for meningitis, sinusitis, conjunctivitis, otitis media, and endocarditis |
| 05/01/2001 | US6225073 Immunoassay for mycophenolic acid |
| 05/01/2001 | US6225070 Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma |
| 05/01/2001 | US6225054 Compositions and methods for the treatment and diagnosis of breast cancer |
| 05/01/2001 | US6225048 Culturing monocytes in fluid communication with viable, allogenically stimulated peripheral blood mononuclear cells to cause differentiation into macrophages, then permitting replication of latent or exogenous virus |
| 05/01/2001 | US6224902 Mixture of delivery vehicle and sterol |
| 05/01/2001 | US6224881 DNA molecule fragments encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 05/01/2001 | US6224869 Isolated polypeptide |
| 05/01/2001 | US6224868 Reagent and processes for targeting mutant epidermal growth factor receptors |
| 05/01/2001 | US6224866 Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors |
| 05/01/2001 | US6224865 Suppression of inhibitors |
| 05/01/2001 | US6224848 Pharmaceuticals providing diagnosis and selective tissue necrosis using Mossbauer absorber atom |
| 05/01/2001 | CA2081660C Method for improving the organoleptic qualities of the meat from uncastrated male domestic animals and vaccine set for use in this method |
| 05/01/2001 | CA1341223C Dna clone of human tissue factor inhibitor |
| 05/01/2001 | CA1341222C Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp |
| 04/26/2001 | WO2001029564A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029256A2 Cephalic pain susceptibility marker |
| 04/26/2001 | WO2001029255A2 Diagnostic test for cephalic pain |
| 04/26/2001 | WO2001029247A1 Stabilized proteins |
| 04/26/2001 | WO2001029246A1 Process for producing polypeptide |
| 04/26/2001 | WO2001029240A2 Regeneration |
| 04/26/2001 | WO2001029226A2 Apoptosis inducing proteinaceous substance |
| 04/26/2001 | WO2001029218A2 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 04/26/2001 | WO2001029207A1 Antiuracil monoclonal antibody |
| 04/26/2001 | WO2001029197A2 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 04/26/2001 | WO2001029178A2 Epo primary response gene 1, eprg1 |
| 04/26/2001 | WO2001029085A2 Cdt6 can inhibit angiogenesis and tumor growth, and can induce or enhance the formation of structures containing collagen v |
| 04/26/2001 | WO2001029083A1 POLYNUCLEOTIDES ENCODING HUMAN AND MURINE ADHESION PROTEINS (BIgR) |
| 04/26/2001 | WO2001029079A1 IMMUNO-INTERACTIVE FRAGMENTS OF THE αC SUBUNIT OF INHIBIN |
| 04/26/2001 | WO2001029072A2 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 04/26/2001 | WO2001029071A2 Genes associated with obesity and methods for using the same |
| 04/26/2001 | WO2001029068A2 A eag gene encoding for a potassium channel |
| 04/26/2001 | WO2001029063A2 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029058A1 Rna interference pathway genes as tools for targeted genetic interference |
| 04/26/2001 | WO2001029056A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | WO2001028586A1 Method of treating fibrosis |
| 04/26/2001 | WO2001028569A1 Targeted vectors |
| 04/26/2001 | WO2001005970A3 Gtp-binding protein associated factors |
| 04/26/2001 | WO2000077040A3 Human intracellular signaling molecules |
| 04/26/2001 | WO2000074703A3 Therapeutic agent comprising a botulinum neurotoxin |
| 04/26/2001 | WO2000068371A8 Method of cell cultivation |
| 04/26/2001 | WO2000061612A3 Compounds and methods for therapy and diagnosis of lung cancer |
| 04/26/2001 | WO2000056889A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/26/2001 | WO2000051628A3 Methods of modulating lipid metabolism and storage |
| 04/26/2001 | WO2000049050A3 Use of blocking anti-tsh-receptor-antibodies in the therapy of hyperthyreoses and monoclonal antibodies for a use of this type |
| 04/26/2001 | WO1997035884A8 Improved production of antibodies through the use of combinations of antigen and antibody, test kits incorporating said antibodies, and medical uses of said antibodies |
| 04/26/2001 | CA2388450A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | CA2388386A1 A new eag gene |
| 04/26/2001 | CA2388346A1 A method for stimulating root or shoot initiation in plant tissue culture by introducing a recombinant receptor kinase gene |
| 04/26/2001 | CA2388032A1 Polynucleotides encoding human and murine adhesion proteins (bigr) |
| 04/26/2001 | CA2387928A1 Genes associated with obesity and methods for using the same |
| 04/26/2001 | CA2387864A1 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 04/26/2001 | CA2387731A1 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 04/26/2001 | CA2386922A1 Novel polypeptides and polynucleotides encoding same |
| 04/26/2001 | CA2386626A1 Targeted vectors |
| 04/26/2001 | CA2386596A1 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 04/26/2001 | CA2386270A1 Rna interference pathway genes as tools for targeted genetic interference |
| 04/26/2001 | CA2384841A1 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | CA2384264A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 04/25/2001 | EP1094113A1 Regeneration |
| 04/25/2001 | EP1094110A1 Apoptosis inducing proteinaceous substance |
| 04/25/2001 | EP1094109A2 Human G protein-coupled receptor, PFI-010 |
| 04/25/2001 | EP1094108A2 DNA mutagenesis by random fragmentation and reassembly for antibody production |
| 04/25/2001 | EP1094080A2 Anti-dnase-gamma antibody, and production and use thereof |
| 04/25/2001 | EP1094076A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094075A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094070A2 Lawsonia intracellularis proteins, and related methods and materials |
| 04/25/2001 | EP1094069A1 DNA encoding structural protein-1 of infectious salmon anaemia virus and uses thereof |
| 04/25/2001 | EP1093521A2 Human transferases |
| 04/25/2001 | EP1093517A2 Neisseria meningitidis antigens and compositions |
| 04/25/2001 | EP1093516A2 Mammalian genes; dendritic cell prostaglandin-like transporter (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 04/25/2001 | EP1093464A2 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/25/2001 | EP1093461A1 Microsporidium polar tube proteins, nucleic acids coding for said proteins and their uses |